The Effect of Aerobic Exercise and Green Coffee on Liver Lipid Metabolism in Obese C57BL/6 Mice

Document Type : Research Paper

Authors

1 Department of Exercise Physiology, Faculty of Sports Sciences, Isfahan University, Isfahan, Iran

2 sport physiology,sport science,esfahan univercity,esfahan,iran

3 Department of Molecular Cell, Isfahan Royan Biotechnology Research Institute, Isfahan, Iran

Abstract
Background and Purpose
Given the critical importance of liver health and its vital role in maintaining the body's metabolic homeostasis, it is imperative to investigate effective non-pharmacological interventions that can enhance hepatic function. Aerobic exercise training and green coffee bean supplementation have emerged as two promising modalities with potential synergistic effects on lipid metabolism. This study aimed to comprehensively evaluate the individual and combined effects of these interventions on hepatic lipid metabolism in a high-fat diet-induced obese C57BL/6 mouse model, which closely mimics human metabolic dysfunction.
The global epidemic of obesity and metabolic syndrome has underscored the urgent need for effective lifestyle interventions. Aerobic exercise has been well-documented to improve cardiovascular fitness and metabolic parameters through multiple pathways including enhanced mitochondrial biogenesis and improved insulin sensitivity. Concurrently, green coffee, rich in chlorogenic acids and other bioactive compounds, has demonstrated potent antioxidant and anti-inflammatory properties that may beneficially modulate lipid metabolism. However, the potential synergistic effects of combining these interventions on hepatic steatosis and related metabolic pathways remain insufficiently explored.
 
Materials and Methods
This experimental study employed a rigorous multi-group post-test design utilizing 28 male C57BL/6 mice (age: 4 weeks; initial weight: 13-15g) obtained from the Royan Institute. Animals were maintained under strictly controlled environmental conditions (12:12 light-dark cycle, 23°C ambient temperature, 50-60% humidity) with ad libitum access to water and a high-fat diet (60% fat, 20% protein, 20% carbohydrates) throughout the 22-week study period. The experimental protocol consisted of two distinct phases: A 12-week obesity induction phase where all animals received the high-fat diet; A subsequent 10-week intervention phase where animals were assigned into four experimental groups: 1) Green coffee supplementation group (GC); 2) Aerobic exercise training group (Ex); 3) Green coffee supplementation + Aerobic exercise training group (Ex+GC); and 4) High-fat diet control group (HFD).
The exercise protocol involved progressive treadmill running (5 sessions/week, 45 minutes/session) with intensity systematically increased from 15 m/min (weeks 1-2) to 23 m/min (weeks 9-10). Each session incorporated a standardized warm-up (3 minutes), main exercise bout (40 minutes), and cool-down period (2 minutes). Animals were acclimated to treadmill running prior to the intervention phase. Comprehensive metabolic assessments included anthropometric measurements (body weight, liver weight), biochemical analyses (fasting blood glucose, plasma insulin), and molecular analyses of key lipid metabolic regulators (Srebp1c, Acc1, Gpat1, Fasn, Cpt1, Ppara) were done using standard techniques.
 
Findings
The high-fat diet successfully induced metabolic dysfunction, with control animals exhibiting significant (P < 0.05) increases in body weight (45.2 ± 3.1g vs. baseline 14.3 ± 0.8g), liver weight (2.8 ± 0.3g vs. 0.9 ± 0.1g), fasting blood glucose (185 ± 12 mg/dL vs. 95 ± 8 mg/dL), and plasma insulin (3.8 ± 0.4 ng/mL vs. 0.9 ± 0.1 ng/mL) compared to baseline values.
All intervention groups demonstrated significant metabolic improvements compared to HFD controls:
Body Weight

GC group: 38.4 ± 2.7g (P = 0.0118)
Ex group: 35.1 ± 2.3g (P < 0.0001)
Ex+GC group: 32.6 ± 2.1g (P < 0.0001)

Liver Weight:

GC group: 2.1 ± 0.2g (P = 0.0283)
Ex group: 1.9 ± 0.2g (P = 0.0031)
Ex+GC group: 1.7 ± 0.1g (P < 0.0001)

Glucose Metabolism: All intervention groups showed significantly lower fasting glucose (P < 0.0001) and insulin levels (P < 0.0001) compared to HFD controls.
Molecular analyses revealed complex modulation of lipid metabolic pathways: in GC group, significant downregulation of Srebp1c (P < 0.001), Acc1 (P < 0.001), and Gpat1 (P < 0.001) but paradoxical upregulation of Fasn (P < 0.001) and downregulation of Cpt1/Ppara (P < 0.001) were seen. Consistent reduction in lipid synthesis enzymes (except Acc1) and beta-oxidation markers were observed in Ex group. And, in Ex+GC group, data demonstrated synergistic effects with approximately 2-fold greater reductions in lipid synthesis markers compared to single interventions.
Conclusion
This comprehensive investigation demonstrates that both aerobic exercise training and green coffee supplementation independently improve metabolic parameters in diet-induced obese mice, with the combined intervention yielding superior results. The findings suggest that these non-pharmacological approaches may represent an effective strategy for preventing hepatic steatosis and related metabolic disorders. The molecular data indicate complex interactions between these interventions and key regulatory pathways of lipid metabolism that warrant further investigation.
 Article Message
This study investigated the combined effects of regular aerobic exercise and green coffee consumption on hepatic lipid metabolism in high-fat diet-fed rats. The results demonstrated that both interventions independently improved liver fat content and regulated key enzymes involved in fatty acid synthesis and β-oxidation. However, the combination of aerobic exercise and green coffee supplementation showed the most significant benefits in optimizing hepatic lipid profiles and reducing metabolic risk factors.
The findings suggest that aerobic training can serve as an effective non-pharmacological approach for managing fatty liver disease and obesity-related metabolic disorders. Additionally, green coffee extract may mimic some beneficial effects of exercise, offering a potential complementary strategy for individuals with physical activity limitations. These results provide a foundation for future research on combined lifestyle and nutraceutical interventions to prevent and treat hepatic diseases.
 Ethical Considerations
This study was approved by the Royan Institute Ethics Committee (IR.ACECR.ROYAN.REC.1399.075) and conducted in accordance with international guidelines for animal research.
Funding
This research was fully supported by internal funding from the first author.
Authors' Contributions
Study design: SMM, MHN-E; Data collection: SS, ZG, FJG; Molecular analyses: ZS; Data interpretation: MA, SMM; Manuscript preparation: SS, SMM; Final approval: all authors.
Conflicts of Interest
The Authors Declare no Competing Financial or Professional Interests.
 

Keywords

Main Subjects


  1. Lee EC, Anand VV, Razavi AC, Alebna PL, Muthiah MD, Siddiqui MS, et al. The global epidemic of metabolic fatty liver disease. Current Cardiology Reports. 2024;26:199-210.
  2. Su W, Chen M, Xiao L, Du S, Xue L, Feng R, Ye W. Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease. Frontiers in Public Health. 2022;10:1047794.
  3. Caldart F, de Pretis N, Luchini C, Ciccocioppo R, Frulloni L. Pancreatic steatosis and metabolic pancreatic disease: a new entity? Internal and Emergency Medicine. 2023;18(8):2199-208.
  4. Khamseh ME, Malek M, Jahangiri S, Nobarani S, Hekmatdoost A, Salavatizadeh M, et al. Insulin resistance/sensitivity measures as screening indicators of metabolic-associated fatty liver disease and liver fibrosis. Digestive Diseases and Sciences. 2024;1:1-14.
  5. Benites-Zapata VA, Bohorquez-Medina SL, Bohorquez-Medina AL. Markers of liver function and insulin resistance. In: Biomarkers in diabetes. Cham: Springer; 2022. pp. 195-216.
  6. Imamura F, Fretts AM, Marklund M, Ardisson Korat AV, Yang W-S, Lankinen M, et al. Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: a pooled analysis of prospective cohort studies. PLoS Medicine. 2017;(6):e1003102.
  7. Hydes TJ, Ravi S, Loomba R, Gray ME. Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH. Clinical and Molecular Hepatology. 2020;26(4):383.
  8. Ramasubbu K, Devi Rajeswari V. Impairment of insulin signaling pathway PI3K/Akt/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective review. Molecular and Cellular Biochemistry. 2023;478(6):1307-24.
  9. Hodson L, Rosqvist F, Parry SA. The influence of dietary fatty acids on liver fat content and metabolism. Proceedings of the Nutrition Society. 2020;79(1):30-41.
  10. Sorriento D, Di Vaia E, Iaccarino G. Physical exercise: a novel tool to protect mitochondrial health. Frontiers in Physiology. 2021;12:660068.
  11. Lim AY, Chen Y-C, Hsu C-C, Fu T-C, Wang J-S. The effects of exercise training on mitochondrial function in cardiovascular diseases: A systematic review and meta-analysis. International Journal of Molecular Sciences. 2022;23(20):12559.
  12. Abdollahi M, Marandi SM, Ghaedi K, Safaeinejad Z, Kazeminasab F, Shirkhani S, et al. Insulin-related liver pathways and the therapeutic effects of aerobic training, green coffee, and chlorogenic acid supplementation in prediabetic mice. Oxidative Medicine and Cellular Longevity. 2022;2022.
  13. Xie MinHao XM, Chen GuiJie CG, Wan Peng WP, Dai ZhuQing DZ, Zeng XiaoXiong ZX, Sun Yi SY. Effects of dicaffeoylquinic acids from Ilex kudingcha on lipid metabolism and intestinal microbiota in high-fat-diet-fed mice. J Agric Food Chem. 2019;67(1):171-83.
  14. Farah A, de Paula Lima J. Consumption of chlorogenic acids through coffee and health implications. Beverages. 2019;5(1):11.
  15. Organization WH. WHO guidelines on physical activity and sedentary behaviour. World Health Organization; 2020.
  16. Cho Y, Lee SY. Useful biomarkers of metabolic syndrome. MDPI; 2022. p. 15003.
  17. Handelsman Y, Lepor NE. PCSK9 inhibitors in lipid management of patients with diabetes mellitus and high cardiovascular risk: a review. Journal of the American Heart Association. 2018;7(13):e008953.
  18. Brellenthin AG, Lee D-c, Bennie JA, Sui X, Blair SN. Resistance exercise, alone and in combination with aerobic exercise, and obesity in Dallas, Texas, US: A prospective cohort study. PLoS Medicine. 2021;1(6):e1003687.
  19. Zheng Y, Yang W, Sun W, Chen S, Liu D, Kong X, et al. Inhibition of porcine pancreatic α-amylase activity by chlorogenic acid. Journal of Functional Foods. 2020;64:103587.
  20. Zheng YuXue ZY, Yang WenHan YW, Sun WeiXuan SW, Chen ShiGuo CS, Liu DongHong LD, Kong XiangLi KX, et al. Inhibition of porcine pancreatic α-amylase activity by chlorogenic acid. Journal of Functional Foods. 2020;64:103587.
  21. Wada M, Yukawa K, Ogasawara H, Suzawa K, Maekawa T, Yamamoto Y, et al. GPR52 accelerates fatty acid biosynthesis in a ligand-dependent manner in hepatocytes and in response to excessive fat intake in mice. Iscience. 2021;24(4):102260.
  22. Wallace M, Metallo CM, editors. Tracing insights into de novo lipogenesis in liver and adipose tissues. Seminars in Cell & Developmental Biology. 2020;108:65-71.
  23. Gavito AL, Bautista D, Suarez J, Badran S, Arco R, Pavón FJ, et al. Chronic IL-6 administration desensitizes IL-6 response in liver, causes hyperleptinemia and aggravates steatosis in diet-induced-obese mice. PloS one. 2016;11(6):e0157956.
  24. Guo Y-X, Wang B-Y, Gao H, Hua R-X, Gao L, He C-W, et al. Peroxisome proliferator–activated receptor-α: a pivotal regulator of the gastrointestinal tract. Frontiers in Molecular Biosciences. 2022;9:864039.
  25. Schlaepfer IR, Joshi M. CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential. Endocrinology. 2020;161(2):bqz046.
  26. Muscella A, Stefàno E, Lunetti P, Capobianco L, Marsigliante S. The regulation of fat metabolism during aerobic exercise. Biomolecules. 2020;10(12):1699.
  27. Pino-de la Fuente F, Quezada L, Sepúlveda C, Monsalves-Alvarez M, Rodríguez JM, Sacristán C, et al. Exercise regulates lipid droplet dynamics in normal and fatty liver. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 2019;1864(12):1585.
  28. Eftekharzadeh M, Atashak S, Azarbayjani MA, Moradi L, Rahmati-Ahmadabad S. The effect of aerobic exercise on SREBP-1c gene expression in skeletal muscle in obese female rats. Thrita. 2023;12(1):1-20.
  29. Dungubat E, Watabe S, Togashi-Kumagai A, Watanabe M, Kobayashi Y, Harada N, et al. Effects of caffeine and chlorogenic acid on nonalcoholic steatohepatitis in mice induced by choline-deficient, L-amino acid-defined, high-fat diet. Nutrients. 2020;12(12):3886.
  30. Farias-Pereira R, Park C-S, Park Y. Mechanisms of action of coffee bioactive components on lipid metabolism. Food Science and Biotechnology. 2019;28(5):1287-96.
  31. Wang W, Li L, Wang X. Therapeutic targets during mitochondrial lipid metabolism. Cham: Springer; 2020. pp. 205-8.
  32. Calle P, Muñoz A, Sola A, Hotter G. CPT1a gene expression reverses the inflammatory and anti-phagocytic effect of 7-ketocholesterol in RAW264. 7 macrophages. Lipids in Health and Disease. 2019;18:1-10.

  • Receive Date 05 July 2024
  • Revise Date 06 February 2025
  • Accept Date 08 May 2025